Reduced incidence and severity of collagen-induced arthritis in interleukin-32-deficient mice

被引:145
作者
McIntyre, KW
Shuster, DJ
Gillooly, KM
Warrier, RR
Connaughton, SE
Hall, LB
Arp, LH
Gately, MK
Magram, J
机构
[1] HOFFMANN LA ROCHE INC, DEPT INFLAMMAT AUTOIMMUNE DIS, NUTLEY, NJ 07110 USA
[2] HOFFMANN LA ROCHE INC, DEPT TOXICOL & PATHOL, NUTLEY, NJ 07110 USA
关键词
interleukin-12; arthritis; autoimmunity;
D O I
10.1002/eji.1830261219
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Collagen-induced arthritis (CIA) is an animal model for rheumatoid arthritis. The disease is elicited by immunization of genetically susceptible DBA/1 mice with type II collagen, resulting in a debilitating arthritis characterized by inflammation and involvement of multiple joints. We investigated the role of endogenous interleukin (IL)-12 in the pathogenesis of this disease by undertaking an analysis of IL-12-deficient mice on the DBA/1 genetic background after immunization with type II collagen. Both the incidence and severity of disease were significantly reduced in mice unable to produce biologically active IL-12. Concomitant decreases were observed in serum levels of pathogenic, collagen-specific IgG2a antibodies and collagen-induced secretion of interferon-gamma by immune splenocytes in vitro, consistent with an impaired T helper-1 response. There were, however, a few animals which developed severe disease in a single paw in spite of this highly diminished Th1 response. Taken together, these results demonstrate an important role for IL-12 in the pathogenesis of CIA, although it is not absolutely required for disease development.
引用
收藏
页码:2933 / 2938
页数:6
相关论文
共 24 条
[1]   INTERLEUKIN-12 ALTERS THE ISOTYPE-RESTRICTED ANTIBODY-RESPONSE OF MICE TO HEN EGG-WHITE LYSOZYME [J].
BUCHANAN, JM ;
VOGEL, LA ;
VANCLEAVE, VH ;
METZGER, DW .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (09) :1519-1528
[2]   IMMUNIZATION AGAINST HETEROLOGOUS TYPE-II COLLAGEN INDUCES ARTHRITIS IN MICE [J].
COURTENAY, JS ;
DALLMAN, MJ ;
DAYAN, AD ;
MARTIN, A ;
MOSEDALE, B .
NATURE, 1980, 283 (5748) :666-668
[3]   PREVENTION OF COLLAGEN-INDUCED ARTHRITIS WITH AN ANTIBODY TO GP39, THE LIGAND FOR CD40 [J].
DURIE, FH ;
FAVA, RA ;
FOY, TM ;
ARUFFO, A ;
LEDBETTER, JA ;
NOELLE, RJ .
SCIENCE, 1993, 261 (5126) :1328-1330
[4]  
FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511
[5]   ADMINISTRATION OF RECOMBINANT IL-12 TO NORMAL MICE ENHANCES CYTOLYTIC LYMPHOCYTE ACTIVITY AND INDUCES PRODUCTION OF IFN-GAMMA IN-VIVO [J].
GATELY, MK ;
WARRIER, RR ;
HONASOGE, S ;
CARVAJAL, DM ;
FAHERTY, DA ;
CONNAUGHTON, SE ;
ANDERSON, TD ;
SARMIENTO, U ;
HUBBARD, BR ;
MURPHY, M .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (01) :157-167
[6]   ADMINISTRATION OF INTERLEUKIN-12 IN COMBINATION WITH TYPE-II COLLAGEN INDUCES SEVERE ARTHRITIS IN DBA/1 MICE [J].
GERMANN, T ;
SZELIGA, J ;
HESS, H ;
STORKEL, S ;
PODLASKI, FJ ;
GATELY, MK ;
SCHMITT, E ;
RUDE, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4823-4827
[7]   INTERLEUKIN-12 PROFOUNDLY UP-REGULATES THE SYNTHESIS OF ANTIGEN-SPECIFIC COMPLEMENT-FIXING IGG2A, IGG2B AND IGG3 ANTIBODY SUBCLASSES IN-VIVO [J].
GERMANN, T ;
BONGARTZ, M ;
DLUGONSKA, H ;
HESS, H ;
SCHMITT, E ;
KOLBE, L ;
KOLSCH, E ;
PODLASKI, FJ ;
GATELY, MK ;
RUDE, E .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (03) :823-829
[8]   High doses of Interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant [J].
Hess, H ;
Gately, MK ;
Rude, E ;
Schmitt, E ;
Szeliga, J ;
Germann, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :187-191
[9]   CHARACTERIZATION OF THE ANTIBODY-RESPONSE IN MICE WITH TYPE-II COLLAGEN-INDUCED ARTHRITIS, USING MONOCLONAL ANTI-TYPE II COLLAGEN ANTIBODIES [J].
HOLMDAHL, R ;
RUBIN, K ;
KLARESKOG, L ;
LARSSON, E ;
WIGZELL, H .
ARTHRITIS AND RHEUMATISM, 1986, 29 (03) :400-410
[10]   IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses [J].
Magram, J ;
Connaughton, SE ;
Warrier, RR ;
Carvajal, DM ;
Wu, CY ;
Ferrante, J ;
Stewart, C ;
Sarmiento, U ;
Faherty, DA ;
Gately, MK .
IMMUNITY, 1996, 4 (05) :471-481